{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-26-036032","form_type":"8-K","ticker":"PCSA","cik":"0001533743","company_name":"Processa Pharmaceuticals, Inc.","filed_at":"2026-08-04T21:25:40+00:00","discovered_at":"2026-08-04T21:26:02.166095+00:00","generated_at":"2026-08-04T21:26:12.653317+00:00","sec_items":["5.02","5.07","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Processa shareholders approve 200,000-share increase to 2019 Omnibus Incentive Plan at annual meeting","bullets":["All six director nominees elected with votes for ranging from 696,796 to 710,505; broker non-votes 825,288.","Amendment to 2019 Omnibus Incentive Plan to increase shares by 200,000 approved: 579,877 for, 152,958 against, 2,700 abstain.","Ratification of Cherry Bekaert as auditor: 1,541,664 for, 12,770 against, 6,389 abstain.","Advisory say-on-pay approved: 640,726 for, 89,886 against, 4,923 abstain."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-036032","json":"https://secwatch.observer/filing/0001493152-26-036032.json","markdown":"https://secwatch.observer/filing/0001493152-26-036032.md","text":"https://secwatch.observer/filing/0001493152-26-036032.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/0001493152-26-036032-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1533743/000149315226036032/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-04T21:26:12.653317+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}